Type-2 diabetes risk lowered by lorcaserin in people who have cardiovascular disease or obesity
Lorcaserin lowers the risk of adults with obesity or cardiovascular disease developing type-2 diabetes, according to research presented at European Association for the Study of Diabetes meeting.Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Heart | Obesity | Study